Topical tacrolimus ointment for the treatment of lichen sclerosus, comparing genital and extragenital involvement

Journal of Dermatology

Volumn 39, Issue 2, 2012, Pages 145-150

  Kim, Gun Wook ^a   Park, Hyun Je ^a   Kim, Hoon Soo ^a   Kim, Su Han ^a   Ko, Hyun Chang ^a   Kim, Byung Soo ^a   Kim, Moon Bum ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

lichen sclerosus; lichen sclerosus et atrophicus; tacrolimus

Indexed keywords

TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; BURNING SENSATION; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; MALE; OUTCOME ASSESSMENT; PRURITUS; RELAPSE; SCHOOL CHILD; TREATMENT DURATION; UROGENITAL TRACT DISEASE;

ADOLESCENT; ADULT; AGED; CHILD; CHRONIC DISEASE; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LICHEN SCLEROSUS ET ATROPHICUS; MALE; MIDDLE AGED; OINTMENTS; TACROLIMUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856251658     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2011.01384.x     Document Type: Article

References (20)

1. Hengge UR,. Lichen sclerosus. In:, Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Fitzpatrick TB, eds. Fitzpatrick's dermatology in general medicine, 7th edn. New York: McGraw-Hill Medical, 2008; 546-550.
2. Powell JJ, Wojnarowska F,. Lichen sclerosus. Lancet 1999; 353: 1777-1783. (Pubitemid 29240387)
3. Carlson JA, Lamb P, Malfetano J, Ambros RA, Mihm MC Jr,. Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases. Mod Pathol 1998; 11: 844-854. (Pubitemid 28440881)
4. Reitamo S, Rissanen J, Remitz A, et al. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol 1998; 111: 396-398. (Pubitemid 28400083)
5. Lubach D, Rath J, Kietzmann M,. Skin atrophy induced by initial continuous topical application of clobetasol followed by intermittent application. Dermatology 1995; 190: 51-55.
6. Woo DK, James WD,. Topical tacrolimus: a review of its uses in dermatology. Dermatitis 2005; 16: 6-21. (Pubitemid 40664284)
7. Cheer SM, Plosker GL,. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis. Am J Clin Dermatol 2001; 2: 389-406. (Pubitemid 34017044)
8. Nasr IS,. Topical tacrolimus in dermatology. Clin Exp Dermatol 2000; 25: 250-254. (Pubitemid 30340561)
9. Haapasaari KM, Risteli J, Koivukangas V, Oikarinen A,. Comparison of the effect of hydrocortisone, hydrocortisone-17-butyrate and betamethasone on collagen synthesis in human skin in vivo. Acta Derm Venereol 1995; 75: 269-271.
10. Reitamo S, Wollenberg A, Schopf E, et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol 2000; 136: 999-1006. (Pubitemid 30629127)
11. Yesudian PD,. The role of calcineurin inhibitors in the management of lichen sclerosus. Am J Clin Dermatol 2009; 10: 313-318.
12. Kunstfeld R, Kirnbauer R, Stingl G, Karlhofer FM,. Successful treatment of vulvar lichen sclerosus with topical tacrolimus. Arch Dermatol 2003; 139: 850-852. (Pubitemid 36898918)
13. Bohm M, Frieling U, Luger TA, Bonsmann G,. Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol 2003; 139: 922-924. (Pubitemid 36898929)
14. Assmann T, Becker-Wegerich P, Grewe M, Megahed M, Ruzicka T,. Tacrolimus ointment for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol 2003; 48: 935-937. (Pubitemid 36706230)
15. Virgili A, Lauriola MM, Mantovani L, Corazza M,. Vulvar lichen sclerosus: 11 women treated with tacrolimus 0.1% ointment. Acta Derm Venereol 2007; 87: 69-72. (Pubitemid 46225394)
16. Hengge UR, Krause W, Hofmann H, et al. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol 2006; 155: 1021-1028. (Pubitemid 44564514)
17. Bornhovd E, Burgdorf WHC, Wollenberg A,. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases. J Am Acad Dermatol 2001; 45: 736-743. (Pubitemid 33032572)
18. Kreuter A, Gambichler T, Sauermann K, Jansen T, Altmeyer P, Hoffmann K,. Extragenital lichen sclerosus successfully treated with topical calcipotriol: evaluation by in vivo confocal laser scanning microscopy. Br J Dermatol 2002; 146: 332-333. (Pubitemid 34264413)
19. Kreuter A, Gambichler T, Avermaete A, et al. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study. J Am Acad Dermatol 2002; 46: 251-255. (Pubitemid 34118383)
20. Arican O, Ciralik H, Sasmaz S,. Unsuccessful treatment of extragenital lichen sclerosus with topical 1% pimecrolimus cream. J Dermatol 2004; 31: 1014-1017. (Pubitemid 40144005)